Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall seroquelA study that was released in August 2003 found three commonly prescribed schizophrenia drugs, including Seroquel, increase the risk of diabetes compared to older antipsychotic drugs. While the number of Seroquel patients found to be suffering from the adverse effect was lesser than other drugs, it was believed that it might have been because of the smaller number of subjects that took Seroquel. A growing number of reports have been finding a link between some atypical antipsychotic drugs and Type 2 diabetes.
The study was based on medical records gathered from 19,978 U.S. military veterans and resulted in Seroquel class action lawsuits to be filed. The Seroquel class action lawsuit was filed on behalf of Seroquel patients put at risk for suffering a high rate of diabetes without being adequately warned. According to the Seroquel class action lawsuit, the company was aware of the risk for diabetes and even had detailed warnings about it on Japanese Seroquel labels.
In addition, the Seroquel class action lawsuit alleged the drug company aggressively marketed the drug despite realizing the risks it posed and for indications not FDA approved. Drug companies have been criticized for having too much power and influence over the FDA and for being motivated by financial rewards that overshadow safety.